- The trend backdrop is active with a 8-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
MEDANTA
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Global Health Limited · Healthcare · Medical Care Facilities
Latest close
1,456 INR
2.9%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 23.0% above the Trend Line and sits at 94.7% of its 52-week range. The latest completed week returned 2.9%, after a 8.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 63/100. Near-term considerations: price is close to its 52-week high.
Setup score
76
out of 100
Latest Close
1,456 INR
7 Aug 2026
1W Return
2.9%
latest completed week
4W Return
8.9%
short-term follow-through
12W Return
17.2%
quarterly tape
Trend Breadth
40.4%
21 of 52 weeks active
Volume Ratio
2.0x
vs 13-week average
- 6 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.9%
Latest completed week; four-week move 8.9%.
Indicator stack
50/87
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 57.81%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
63/100
25 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 23.0% above the Trend Line and sits at 94.7% of its 52-week range. The latest completed week returned 2.9%, after a 8.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9012-week average 0.54
12-week confirmation
Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.90Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers66 reversal markers
No recent accumulation markers. 6 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 8.9% over four weeks, 17.2% over 12 weeks, and 2.3% over one year. The current trend has remained active for 8 consecutive weeks.
Performance by holding period
Active trend streak8 weeks
Active weeks in one year21
Trend breadth40.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.85Latest activity-pressure read.
Pressure change42.2%Four-week change in activity pressure.
Leadership19.66Latest relative-leadership reading.
RS change63.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength21/100Blend of value, momentum, and quality. Underlying universe rank 80; rank 1 is best.
Value5/100Relative valuation strength. Underlying universe rank 96; rank 1 is best.
Quality76/100Profitability and accounting quality. Underlying universe rank 25; rank 1 is best.
Momentum63/100Medium-term price momentum. Underlying universe rank 38; rank 1 is best.
Growth73/100Revenue and earnings growth. Underlying universe rank 28; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework15/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 70.3x Price divided by trailing earnings.
- Price / sales
- 8.9x Market value relative to trailing revenue.
- EV / EBITDA
- 39.5x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -0.7% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 77.4% Gross profit retained from each unit of revenue.
- Operating margin
- 15.8% Operating profit retained from revenue.
- Free-cash-flow margin
- -6.0% Free cash flow generated from revenue.
- Return on invested capital
- 10.4% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 19.4% Latest one-year revenue growth.
- EPS growth
- 15.5% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 5/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.0% Cash dividends relative to market value.
- Buyback yield
- -0.0% Net share repurchases relative to market value.
- Shareholder yield
- -0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 1.0x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment63/100
Weighted news tone is positive across 25 relevant articles.
3 positive · 22 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-1.9%Distance below the 52-week high.
13-week volatility2.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+7.5%Week of 8 May.
Worst week-6.2%Week of 20 Mar.
Latest week+2.9%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains11
Flat weeks0
Modest losses10
Sharp losses1
Recent vol2.5%13-week weekly-return volatility.
Base vol3.7%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew2.9% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank17 / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Medical Care Facilities
4-week rank2 / 21
Group average2.1%
Trend breadth85.7%
Trend85.7%active weekly trend signals
MD76.2%positive activity pressure
RS61.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape73/100
Trend, activity pressure, participation, and risk combine to a 73/100 tape read.
Indicator analysis73/100Latest 12-week confirmation: trend 8/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.90; 6 reversal markers Next-Week ExpectancyPositive 57.81%Next-week expectancy is positive with a 57.81% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors40/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 74 SVQF15/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1340.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment63/100Weighted news tone is positive across 25 relevant articles.
What Is Venture Global (VG) Signaling With Its Dividend Hike And LNG Milestone? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1,456 INR | 2.9% | 1,183 INR | 1,158 INR | 1.85 | 19.66 | 1.7M | On |
| 31 Jul 2026 | 1,415 INR | 3.2% | 1,174 INR | 1,153 INR | 1.76 | 17.26 | 1.2M | On |
| 24 Jul 2026 | 1,371 INR | 4.1% | 1,167 INR | 1,148 INR | 1.62 | 16.72 | 1.7M | On |
| 17 Jul 2026 | 1,317 INR | -1.5% | 1,161 INR | 1,144 INR | 1.40 | 9.69 | 346.9K | On |
| 10 Jul 2026 | 1,337 INR | -1.0% | 1,156 INR | 1,140 INR | 1.30 | 12.00 | 738.2K | On |
| 3 Jul 2026 | 1,351 INR | 2.9% | 1,150 INR | 1,136 INR | 1.12 | 13.01 | 177.0K | On |
| 26 Jun 2026 | 1,312 INR | 3.7% | 1,144 INR | 1,131 INR | 1.00 | 11.18 | 0 | On |
| 19 Jun 2026 | 1,266 INR | 2.5% | 1,141 INR | 1,127 INR | 0.92 | 7.86 | 161.7K | On |
| 12 Jun 2026 | 1,235 INR | -0.4% | 1,140 INR | 1,123 INR | 1.00 | 7.31 | 247.6K | Off |
| 5 Jun 2026 | 1,240 INR | 4.3% | 1,138 INR | 1,119 INR | 1.21 | 9.10 | 310.3K | Off |
| 29 May 2026 | 1,189 INR | -4.0% | 1,138 INR | 1,115 INR | 1.33 | 3.99 | 661.1K | Off |
| 22 May 2026 | 1,238 INR | -0.4% | 1,143 INR | 1,112 INR | 1.31 | 7.61 | 958.6K | Off |
| 15 May 2026 | 1,242 INR | 3.5% | 1,146 INR | 1,107 INR | 1.07 | 8.48 | 3.0M | Off |
| 8 May 2026 | 1,201 INR | 7.5% | 1,150 INR | 1,103 INR | 0.71 | 2.69 | 1.1M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.